Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
3.090
+0.050 (1.64%)
At close: Nov 22, 2024, 4:00 PM
3.100
+0.010 (0.32%)
After-hours: Nov 22, 2024, 7:54 PM EST
Xeris Biopharma Holdings Market Cap
Xeris Biopharma Holdings has a market cap or net worth of $460.66 million as of November 22, 2024. Its market cap has increased by 68.51% in one year.
Market Cap
460.66M
Enterprise Value
662.22M
1-Year Change
68.51%
Ranking
Category
Stock Price
$3.09
Market Cap Chart
Since October 6, 2021, Xeris Biopharma Holdings's market cap has increased from $295.78M to $460.66M, an increase of 55.75%. That is a compound annual growth rate of 15.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2024 | 453.21M | 39.62% |
| Dec 29, 2023 | 324.59M | 79.47% |
| Dec 30, 2022 | 180.86M | -50.50% |
| Dec 31, 2021 | 365.40M | 23.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MeiraGTx Holdings | 462.67M |
| Arcturus Therapeutics Holdings | 462.38M |
| Aclaris Therapeutics | 462.18M |
| National Research | 456.84M |
| REGENXBIO | 454.82M |
| Y-mAbs Therapeutics | 452.37M |
| Aura Biosciences | 451.06M |
| Olema Pharmaceuticals | 450.62M |